bf/NASDAQ:CHRS_icon.jpeg

COM:COHERUS

Coherus BioSciences

  • Stock

USD

Last Close

1.10

22/11 21:00

Market Cap

164.06M

Beta: -

Volume Today

2.69M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-4.10M
-
-6.28M
53.14%
-4.60M
26.71%
-2.42M
47.35%
829.50K
134.24%
28.36M
3,319.53%
73.63M
159.58%
92.72M
25.93%
104.15M
12.33%
122.58M
17.69%
average payables
7.24M
-
20.15M
178.22%
25.04M
24.28%
18.15M
27.52%
15.50M
14.57%
20.64M
33.12%
20.59M
0.23%
15.68M
23.86%
13.84M
11.72%
23.37M
68.85%
average receivables
2.31M
-
2.90M
25.45%
1.71M
40.97%
929.50K
45.63%
-871K
193.71%
70.13M
8,151.09%
149.52M
113.22%
140.03M
6.34%
116.49M
16.81%
185.24M
59.02%
book value per share
8.15
-
-0.19
102.29%
0.46
347.39%
0.57
24.45%
-0.59
203.26%
1.51
354.46%
3.93
160.57%
1.30
67.08%
-1.77
236.67%
-2.05
16.04%
capex per share
-0.35
-
-0.17
52.29%
-0.16
6.39%
-0.09
44.63%
-0.01
85.90%
-0.19
1,425.63%
-0.10
46.62%
-0.02
82.71%
-0.03
53.74%
-0.00
88.44%
capex to depreciation
-4.23
-
-3.30
21.98%
-2.17
34.06%
-1.35
38.11%
-0.24
81.88%
-3.96
1,522.56%
-2.44
38.26%
-0.37
84.73%
-0.55
47.71%
-0.39
29.79%
capex to operating cash flow
0.12
-
0.06
52.06%
0.03
54.80%
0.02
11.49%
0.00
78.30%
-0.45
9,281.32%
-0.05
89.94%
0.03
175.23%
0.01
75.44%
0.00
80.66%
capex to revenue
-0.09
-
-0.21
124.03%
-0.03
83.30%
-2.94
8,475.77%
-0.51
82.75%
-0.04
92.86%
-0.01
59.06%
-0.00
73.38%
-0.01
144.76%
-0.00
88.49%
cash per share
18.37
-
4.26
76.80%
2.98
30.06%
2.39
19.88%
1.11
53.42%
2.55
129.18%
7.58
197.20%
5.53
27.03%
2.47
55.35%
1.26
49.16%
days of inventory on hand
1.18K
-
893.33
24.10%
591.01
33.84%
599.20
1.39%
298.67
50.15%
days payables outstanding
555.37
-
147.30
73.48%
102.41
30.47%
60.03
41.39%
80.85
34.69%
days sales outstanding
49.66
-
18.95
61.83%
3.57
81.17%
-408.63
-
145.55
135.62%
120.47
17.23%
137.51
14.14%
190.18
38.31%
369.65
94.36%
debt to assets
0.06
-
0.11
89.42%
0.57
398.66%
0.63
10.32%
1.04
65.81%
0.44
57.91%
0.48
10.04%
0.61
26.27%
0.99
63.10%
0.75
23.95%
debt to equity
0.17
-
-3.48
2,170.23%
5.23
250.03%
3.33
36.30%
-2.67
180.25%
1.70
163.47%
1.44
15.19%
4.21
193.03%
-3.46
182.10%
-2.45
29.26%
dividend yield
earnings yield
-0.65
-
-0.26
59.84%
-0.11
58.80%
-0.51
371.95%
-0.36
30.17%
0.07
120.13%
0.11
48.81%
-0.25
338.74%
-0.53
108.84%
-0.76
42.81%
enterprise value
-16.79M
-
694.10M
4,234.51%
1.16B
66.42%
442.07M
61.73%
619.30M
40.09%
1.26B
102.70%
1.10B
12.05%
1.20B
8.27%
1.02B
14.47%
683.59M
33.14%
enterprise value over ebitda
0.20
-
-3.10
1,637.75%
-9.64
211.02%
-1.93
79.95%
-3.10
60.44%
11.37
466.78%
7.04
38.12%
-4.53
164.30%
-4.04
10.72%
-3.36
16.73%
ev to operating cash flow
0.70
-
-6.43
1,016.07%
-4.57
28.84%
-2.21
51.74%
-3.89
76.17%
44.27
1,238.52%
7.16
83.82%
-31.93
545.84%
-4.24
86.72%
-3.91
7.81%
ev to sales
-0.54
-
23.10
4,381.09%
6.08
73.70%
284.11
4,575.71%
398.01
40.09%
3.53
99.11%
2.32
34.19%
3.66
57.76%
4.84
32.35%
2.66
45.14%
free cash flow per share
-3.27
-
-3.08
5.98%
-6.18
101.00%
-3.86
37.62%
-2.46
36.17%
0.22
109.01%
2.06
828.46%
-0.51
124.92%
-3.13
510.35%
-1.86
40.61%
free cash flow yield
-0.20
-
-0.13
33.17%
-0.22
63.94%
-0.44
99.54%
-0.27
37.93%
0.01
104.53%
0.12
861.85%
-0.03
127.13%
-0.40
1,129.95%
-0.56
41.25%
graham net net
3.54
-
-1.67
147.22%
-0.84
49.77%
-0.10
88.43%
-1.02
946.82%
0.11
111.26%
2.02
1,664.18%
-0.34
116.73%
-3.69
991.42%
-4.72
27.84%
graham number
44.19
-
5.03
88.63%
5.62
11.79%
7.61
35.50%
6.56
13.89%
6.62
0.95%
12.80
93.47%
10.88
15.05%
12.95
19.01%
10.81
16.53%
income quality
0.27
-
0.48
75.70%
1.98
309.82%
0.84
57.47%
0.76
9.52%
0.32
58.50%
1.17
269.28%
0.13
88.81%
0.83
533.89%
0.74
11.05%
intangibles to total assets
0.02
-
0.02
11.85%
0.02
18.99%
0.02
9.76%
0.04
63.48%
0.01
75.68%
0.00
51.41%
0.01
23.89%
0.01
135.17%
0.11
822.93%
interest coverage
-16.59
-
-6.64K
39,926.18%
-14.53
99.78%
-24.30
67.28%
-21.11
13.14%
6.12
129.01%
7.39
20.62%
-11.49
255.61%
-7.91
31.17%
-4.89
38.23%
interest debt per share
1.85
-
0.65
64.78%
2.60
299.91%
2.09
19.61%
1.73
17.14%
2.81
62.20%
5.95
111.69%
5.76
3.23%
6.54
13.54%
5.46
16.57%
inventory turnover
0.31
-
0.41
31.76%
0.62
51.15%
0.61
1.37%
1.22
100.62%
invested capital
0.17
-
-3.48
2,170.23%
5.23
250.03%
3.33
36.30%
-2.67
180.25%
1.70
163.47%
1.44
15.19%
4.21
193.03%
-3.46
182.10%
-2.45
29.26%
market cap
133.60M
-
852.32M
537.95%
1.18B
38.43%
467.58M
60.37%
588.57M
25.88%
1.25B
113.16%
1.24B
1.07%
1.20B
2.98%
614.83M
48.94%
313.56M
49.00%
net current asset value
29.93M
-
-61.09M
304.11%
-34.18M
44.04%
-5.17M
84.89%
-65.70M
1,172.06%
71.02M
208.09%
229.72M
223.46%
51.86M
77.42%
-201.57M
488.67%
-314.66M
56.10%
net debt to ebitda
1.81
-
0.71
60.87%
0.21
70.84%
0.11
45.90%
-0.15
238.03%
0.01
104.23%
-0.87
13,538.49%
0.03
103.86%
-1.61
4,871.27%
-1.82
13.08%
net income per share
-10.64
-
-6.01
43.49%
-3.04
49.48%
-4.48
47.54%
-3.22
28.19%
1.29
140.05%
1.85
43.64%
-4.06
319.24%
-4.21
3.63%
-2.53
39.95%
operating cash flow per share
-2.92
-
-2.91
0.47%
-6.03
107.13%
-3.77
37.44%
-2.45
35.03%
0.41
116.62%
2.16
430.44%
-0.50
122.98%
-3.11
526.07%
-1.86
40.21%
payables turnover
0.66
-
2.48
277.03%
3.56
43.83%
6.08
70.61%
4.51
25.76%
receivables turnover
7.35
-
19.26
161.99%
102.26
431.04%
-0.89
-
2.51
380.74%
3.03
20.82%
2.65
12.39%
1.92
27.70%
0.99
48.55%
research and ddevelopement to revenue
2.51
-
7.09
182.03%
1.34
81.13%
104.36
7,697.54%
70.85
32.11%
0.26
99.63%
0.30
13.42%
1.11
270.62%
0.94
15.05%
0.43
54.96%
return on tangible assets
-0.47
-
-1.07
125.35%
-0.73
31.91%
-1.50
105.71%
-2.18
45.77%
0.22
110.15%
0.16
28.80%
-0.45
387.27%
-0.69
51.73%
-0.43
38.00%
revenue per share
3.80
-
0.81
78.70%
4.54
460.49%
0.03
99.35%
0.02
18.30%
5.11
21,258.24%
6.66
30.39%
4.33
35.04%
2.72
37.19%
2.73
0.49%
roe
-1.31
-
32.22
2,568.62%
-6.58
120.42%
-7.80
18.55%
5.42
169.55%
0.85
84.26%
0.47
44.88%
-3.13
765.98%
2.38
175.83%
1.23
48.26%
roic
-0.68
-
-12.32
1,703.81%
-0.97
92.15%
-1.83
88.79%
-3.24
77.47%
0.36
110.96%
0.22
38.27%
-0.54
346.87%
-0.83
53.01%
-0.69
16.26%
sales general and administrative to revenue
0.56
-
1.20
112.50%
0.27
77.38%
45.82
16,783.78%
60.53
32.08%
shareholders equity per share
8.15
-
-0.19
102.29%
0.46
347.39%
0.57
24.45%
-0.59
203.26%
1.51
354.46%
3.93
160.57%
1.30
67.08%
-1.77
236.67%
-2.05
16.04%
stock based compensation to revenue
0.36
-
0.56
56.52%
0.14
74.09%
23.18
15,969.00%
22.36
3.52%
0.09
99.58%
0.10
1.72%
0.16
63.91%
0.24
52.84%
0.17
30.29%
tangible asset value
63.19M
-
-10.49M
116.60%
15.79M
250.51%
26.97M
70.81%
-42.15M
256.29%
101.65M
341.14%
277.41M
172.91%
94.16M
66.06%
-143.35M
252.23%
-265.10M
84.93%
tangible book value per share
7.72
-
-0.28
103.66%
0.38
233.30%
0.51
34.73%
-0.65
227.69%
1.46
325.07%
3.88
166.29%
1.25
67.87%
-1.77
241.84%
-2.82
59.04%
working capital
98.61M
-
52.21M
47.06%
68.57M
31.34%
98.52M
43.67%
39.09M
60.32%
259.76M
564.44%
708.86M
172.89%
554.44M
21.78%
362.24M
34.67%
338.73M
6.49%

All numbers in USD (except ratios and percentages)